Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia

IF 13 1区医学 Q1 CLINICAL NEUROLOGY

Alzheimer's & Dementia Pub Date : 2025-03-19 DOI:10.1002/alz.14570

Karly A. Cody, Lianlian Du, Rachel L. Studer, Erin M. Jonaitis, Sanjay Asthana, Bradley T. Christian, Nathaniel A. Chin, Kris M. Kirmess, Matthew R. Meyer, Kevin E. Yarasheski, Tim West, Philip B. Verghese, Joel B. Braunstein, Tobey J. Betthauser, Rebecca E. Langhough, Sterling C. Johnson

引用次数: 0

Abstract

Plasma biomarkers sensitive to Alzheimer's disease (AD) proteinopathy prior to the onset of dementia have significant implications for early detection.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Alzheimer's & Dementia 医学-临床神经学

CiteScore

14.50

自引率

5.00%

发文量

299

审稿时长

3 months

期刊介绍： Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.